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Several G-protein coupled receptors, such as the b1-adrenergic
receptor (b1-AR), contain polyproline motifs within their intracel-
lular domains. Such motifs in other proteins are known to mediate
protein–protein interactions such as with Src homology (SH)3
domains. Accordingly, we used the proline-rich third intracellular
loop of the b1-AR either as a glutathione S-transferase fusion
protein in biochemical ‘‘pull-down’’ assays or as bait in the yeast
two-hybrid system to search for interacting proteins. Both ap-
proaches identified SH3p4yp8yp13 (also referred to as endophilin
1y2y3), a SH3 domain-containing protein family, as binding part-
ners for the b1-AR. In vitro and in human embryonic kidney (HEK)
293 cells, SH3p4 specifically binds to the third intracellular loop of
the b1-AR but not to that of the b2-AR. Moreover, this interaction
is mediated by the C-terminal SH3 domain of SH3p4. Functionally,
overexpression of SH3p4 promotes agonist-induced internaliza-
tion and modestly decreases the Gs coupling efficacy of b1-ARs in
HEK293 cells while having no effect on b2-ARs. Thus, our studies
demonstrate a role of the SH3p4yp8yp13 protein family in b1-AR
signaling and suggest that interaction between proline-rich motifs
and SH3-containing proteins may represent a previously undera-
ppreciated aspect of G-protein coupled receptor signaling.
b -adrenergic receptors (bARs) belong to a large family ofG-protein-coupled receptors that contain seven trans-
membrane domains connected by three extracellular loops, three
intracellular loops, and a carboxyl terminal tail. Three bAR
subtypes, b1, b2, and b3, have been identified by molecular
cloning (1). All three bAR subtypes couple to the stimulatory
GTP-binding protein (Gs) to activate adenylyl cyclase. Notably,
the bAR subtypes are distinguishable with respect to tissue
distribution and their regulatory roles in specific physiological
processes (2).
Our knowledge about the molecular mechanisms underlying
bAR signaling has been greatly expanded in the past 10 years,
largely as a result of studies using the b2-AR as a model system
(3). Understanding the biology of both b1-AR and b3-AR
signaling has significantly lagged behind, although it has long
been recognized that the bAR subtypes might undergo distinct
regulation (4–6) and signal through distinct mechanisms.
It has been previously shown by mutagenesis studies that the
specificity of G protein coupling for bAR is dictated by the
intracellular domains, particularly the third intracellular loop
and the C-terminal tail (7, 8). Furthermore, these regions are
also critical for binding of bAR regulatory proteins, primarily the
G protein-coupled receptor kinases (GRKs) and the b-arrestins
(9, 10). On agonist stimulation, GRKs are recruited to the
plasma membrane and phosphorylate the activated b2 receptors
(11). The b-arrestins then bind to the phosphorylated b2 recep-
tors (12) to induce rapid desensitization and internalization of
the receptors.
Close examination of the primary sequences of the b1- and
b2-ARs (13) reveals that their third intracellular loops are highly
conserved except for a 24-aa proline-rich segment in the middle
of the b1 third intracellular loop. It has been suggested that this
motif may be responsible for certain differences between b1-AR
and b2-AR signaling (13). More intriguingly, this sequence
feature also can be found in other G-protein coupled receptors
(GPCRs), including b3-AR, a2A-AR, and dopamine D4 recep-
tors (14). In the case of dopamine D4 receptors, these proline-
rich motifs were demonstrated, in vitro, to serve as potential
ligands for several SH3 domain-containing proteins, such as Nck
and Grb2 (14).
In an attempt to better understand the biology of b1-AR
signaling and the molecular determinants underlying the differ-
ences between b1-AR and b2-AR regulation, we set out to
search for novel binding proteins for the b1-AR by using its third
intracellular loop as bait in several protein interaction systems.
Materials and Methods
Antibodies and Plasmids. Anti-Flag M2 affinity gel and biotin-
ylated M2 anti-Flag antibody were obtained from Sigma. Rabbit
polyclonal anti-hemagglutinin (HA) antibody from Babco
(Richmond, CA) was used to detect HA-tagged proteins.
Streptavidin horseradish peroxidase, anti-mouse horseradish
peroxidase, and anti-rabbit horseradish peroxidase were ob-
tained from Amersham Pharmacia.
The pcDNA3 Flag-b1-AR plasmid was constructed by PCR,
incorporating the HA endoplasmic reticulum targeting peptide
and the FLAG peptide at the amino terminus. The pcDNA3
Flag-b2-AR plasmid was constructed by subcloning the Flag-
b2-AR sequence from pBK-CMV (15) into the BamHI and XbaI
sites of pcDNA3. pcDNA3 Flag-(or HA)-SH3p4 and its mutants
were used as indicated in the figure legends. Glutathione S-
transferase (GST)–ALP1 (amphiphysin-like-protein 1), GST-
Grb2 NSH3, and GST-Grb2 CSH3 constructs were generously
provided by Ann M. Pendergast (Duke University Medical
Center) and GST-Grb2 by A. R. Saltiel (Parke–Davis Pharma-
ceutical Research Institute). GST-Src Src homology (SH)3 con-
struct was described previously (16).
Bovine Brain Tissue Extract Preparation and GST Pull-Down Assay.
GST fusion proteins encoding the b1- and b2-AR third intra-
cellular loops were purified according to manufacturer’s instruc-
tion (Amersham Pharmacia). Frozen bovine brain (80 g) was
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thawed in 200 ml of buffer A (20 mM TriszHCl, pH7.2y5 mM
EDTAy10 mM PMSFy1 mg/ml leupeptiny1 mg/ml pepstatiny1
mg/ml aprotininy10 mg/ml benzamidinezHCl) and was homoge-
nized by using a polytron homogenizer. Brain extracts were
fractionated by centrifugation at 150,000 3 g for 30 min. GST-b1
(or b2) third intracellular loop fusion proteins (1–1.5 mg)
conjugated on glutathione Sepharose 4B beads were subse-
quently added to 10-ml aliquots of the resulting supernatant.
After incubation at 4°C with gentle rotation for 1 hr, the beads
were recovered by centrifugation at 800 3 g for 5 min and were
washed extensively with PBS containing 0.1% Triton X-100.
After washing, GST fusion proteins and putative interacting
proteins were eluted with reduced 10 mM glutathione in 50 mM
TriszHCl (pH 8.0). Where indicated, the elute was concentrated
by using a Centricon (Millipore). Protein concentration was
determined with Bradford reagent (Bio-Rad). SDS sample
buffer was added to the eluted samples, which were subjected to
SDSyPAGE and stained with Coomassie blue. Proteins specif-
ically interacting with GST-b1 third intracellular loop were
subjected to in-gel trypsin digestion and peptide sequencing
(Protein Chemistry Core Facility, Baylor College of Medicine,
Houston, TX).
Yeast Two-Hybrid Screen. The pAS2-1-b1 (third intracellular loop)
plasmid was constructed by PCR using the pcDNA1 HA-b1AR
construct as a template. The yeast PJ-69-4A strain was co-
transformed with the pAS2-1-b1(third intracellular loop) plas-
mid and a rat brain cDNA library (CLONTECH) by using
standard yeast transformation protocols (17, 18). Of ’13 million
independent clones, nine exhibited moderate to strong growth
on either 2His or 2Ade selective plates. The library plasmids
isolated from positive clones then were cotransformed into the
PJ-69-4A strain with either the pAS2-1-b1(third intracellular
loop) plasmid or pAS2-1, and the specificity of the interactions
were confirmed by growth on 2His and 2Ade selective plates
as well as by b-galactosidase activity (Yeast Protocols Hand-
book, CLONTECH).
ELISA Assay for Analyzing Protein Interaction in Vitro. The pET 30a
vector (Novagen) was used to express His-S-tagged b1-AR and
b2-AR third intracellular loops in Escherichia coli, and expressed
proteins were purified according to the manufacturer’s manual.
His-S-tagged b1 or b2 third intracellular loop fusion protein (0.5
mg) diluted in 100 ml of PBS plus a mixture of protease inhibitors
was coated per well in 96-well high affinity binding dishes
(Fisher) overnight at 4°C. After the coating solution was re-
moved, the wells were washed with PBS and then were blocked
with 2% dry milk in PBS for 1 hr at room temperature.
Subsequently, GST fusion proteins diluted in 2% milk in PBS
plus protease inhibitors were added to the precoated wells at the
indicated concentrations and were incubated for 1 hr at room
temperature. After incubation, the wells were extensively washed
with PBS. GST substrate (100 mM potassium phosphate buffer,
pH 6.5y1 mM 1-chloro-2, 4-dinitrobenzeney1 mM reduced
glutathione), 150 ml, was added to each well, and the absorbance
at 340 nm was recorded to determine the reaction kinetics and
endpoint readings. To ensure that equivalent amounts of His-
S-tagged b1and b2 third intracellular loop proteins were bound
to the 96-well dishes, some wells were developed by using anti-S
alkaline phosphatase (Novagen) and alkaline phosphatase sub-
strate (Bio-Rad). As an additional control, the GST activity per
unit protein of the GST fusion proteins used in this study was
determined.
Cell Culture and Transfection. HEK293 cells were maintained in
minimal essential medium plus 10% bovine serum and penicil-
linystreptomycin in a 5% C02 37°C incubator. For co-
immunoprecipitation assays, 2 mg of pcDNA3 Flag-b1-AR or
pcDNA3 Flag-b2-AR with either 4 mg of pcDNA3 HA-SH3p4,
pcDNA3 HA-SH3P4 DSH3 or 4 mg of pcDNA3 empty vector was
cotransfected into 50–80% confluent 10-cm tissue culture plates
by using a calcium-phosphate transfection kit (GIBCOyBRL).
To establish stable HEK293 cell lines, either 4 mg of pcDNA3
HA-SH3p4, pcDNA3 HA-SH3p4 DSH3 or 4 mg of pcDNA3
empty vector was transfected into HEK293 cells and cells
selected with 400 mgyml G418 (GIBCOyBRL) in medium. After
selection for 10–15 days, the colonies were pooled together.
Overexpression of transfected proteins was assessed by Western
blot analysis. Stable cells were cultured in medium containing
200 mgyml G418.
Coimmunoprecipitation. Twenty-four hours after transfection,
HEK293 cells were incubated in serum-free medium overnight
before treatment with 10 mM isoproterenol. Treated plates were
transferred to ice, and cells were lysed with 1 ml of ice-cold
digitonin buffer (20 mM triethanolamine, pH 8.0y300 mM
NaCly2 mM EDTAy20% glyceroly1% digitoinin and protease
inhibitors). The lysate was solubilized by incubation at 4°C for 30
min and was clarified by centrifugation at 21,000 3 g for 20 min.
The concentration of soluble protein was determined with the
BCA protein assay kit (Pierce). Equal amounts of protein was
used for all subsequent immunoprecipitations. A portion (25 ml)
of anti-Flag M2 affinity gel (Sigma) was incubated overnight at
4°C with ’1 ml of cell lysate to precipitate Flag-b1-AR or
Flag-b2-AR. After extensive washing with digitonin buffer,
immunoprecipitated proteins were eluted from the beads with
23 SDS sample buffer, were resolved by SDSyPAGE, and were
subjected to Western blot analysis.
Sequestration Assay and Whole-Cell cAMP Assay. For sequestration
and whole-cell cAMP assays, 0.5–1.0 mg of pcDNA1 HA-b1-AR
or pcDNA1 HA-b2-AR was transfected into HEK293 cells in
10-cm plates to obtain a receptor density of ’500 fmolymg
protein (determined by 125I-cyanopindolol binding assay). After
transfection, cells were split into one collagen-treated 6-well dish
for sequestration assays or two 12-well dishes for cyclase assays.
The sequestration assays were performed essentially as de-
scribed (12). Ten micromolar isoproterenol was used to stimu-
late the cells for 30 min. Sequestration was defined as the
percentage of cell surface receptors lost after agonist treatment.
Whole-cell cAMP was determined as described (19). In brief,
cells in 12-well dishes were labeled with [3H]adenine in growth
medium overnight. Dobutamine was used as a b1-AR agonist,
and endogenous b2-AR-induced adenylyl cyclase activity was
measured by using isoproterenol. Both 125I-cyanopindolol bind-
ing (19) and immunofluorescence flow cytometry was used to
determine total and cell surface HA-b1-AR expression.
Results
Identification of the SH3p4yp8yp13 Protein Family as Binding Partners
for the Proline-Rich Third Intracellular Loop of the b1-Adrenergic
Receptor. To search for potential binding partners for the third
intracellular loop of the b1- andyor b2-AR, we used both a
biochemical approach and the yeast two-hybrid system. In the
biochemical approach, GST fusion proteins encompassing the
third intracellular loop of the b1- and b2-AR were purified from
bacteria, were conjugated to glutathione Sepharose 4B beads,
and were incubated separately with bovine brain extracts. As
shown in Fig. 1A, two proteins of Mr ’40 and ’50 were
recovered from GST-b1-AR third intracellular loop fusion
protein incubations with bovine brain extracts. The binding of
these proteins to the b1-AR third intracellular loop appeared to
be specific because the GST-b2-AR third intracellular loop
fusion protein did not pull out these proteins under the same
experimental conditions (Fig. 1B).
We have initially focused on the 40-kDa protein. To identify
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this protein, the eluted material was concentrated, run on larger-
scale SDSyPAGE, and stained with Coomassie blue. The 40-kDa
peptide then was cut out and subjected to in-gel trypsin digestion
and peptide sequencing. Three major peptide sequences were
obtained (IPDEELRQALEK, QNFIDPLQNL, and DL-
REIQHHLK). BLAST searches of protein sequence databases
revealed that all three fragments matched with sequences of the
SH3p4yp8yp13 protein family. The first two peptide sequences
are identical among all three members of this protein family. The
R in the third peptide is specific to SH3p4. Thus, the 40-kDa
protein we purified from bovine brain extract is SH3p4.
Concurrently, we also used the yeast two-hybrid system to
search for potential binding partners for the b1-AR third
intracellular loop. The b1-AR third intracellular loop was fused
to the GAL4 DNA binding domain and was used as bait to screen
a rat brain cDNA library by using the yeast strain PJ-69-4A.
Approximately 13 million independent clones were analyzed,
and nine exhibited moderate to strong growth on 2HIS or
2ADE media. Strikingly, eight of the nine clones encoded
different versions of cDNAs for either SH3p4 or SH3p13.
Activity of the reporter gene LacZ was measured to assess the
relative affinities of the SH3p4 and SH3p13 clones with the
b1-AR third intracellular loop in the yeast two-hybrid system. As
shown in Table 1, constructs encoding SH3p4 induced the LacZ
reporter gene between 3.09- and 6.24-fold over background
whereas SH3p13 clones activated the reporter from 3.94- to
10.81-fold. The fact that no other SH3-containing protein was
identified in the yeast two-hybrid system strongly suggests that
the SH3p4yp8yp13 family of proteins may be specific binding
partners for the b1-AR in vivo.
In Vitro, SH3p4 Specifically Interacts with the Proline-Rich Third
Intracellular Loop of the b1-AR. To further characterize the inter-
action of SH3p4 with the b1-AR third intracellular loop, we
performed ELISA assays. His-S-tagged b1- and b2-AR third
intracellular loop fusion proteins were purified from E. coli and
were used to coat 96-well dishes. The coated wells then were
overlaid with GST fusion proteins encoding GST alone as a
negative control, or full length SH3p4. The amount of bound
GST fusion protein was detected by measuring the enzymatic
activity of the GST moiety by using a GST substrate. Absorbance
at 340 nm then was recorded to obtain both the reaction kinetics
and endpoint readings. As shown in Fig. 2A, the dose–response
curve of GST-SH3p4 binding with His-S-tagged b1 third intra-
Fig. 1. Purification of GST-b1-AR third intracellular loop binding protein(s)
from bovine brain extracts. A GST pull-down assay was performed, as de-
scribed in Materials and Methods, by using the GST-b1-AR third intracellular
loop (A) and GST-b2-AR third intracellular loop (B), respectively. For each
incubation condition, 5, 10, and 25 mg of proteins was loaded on SDSyPAGE,
stained with Coomassie blue, and dried. A 40-kDa protein, as indicated by an
arrow, was specifically recovered after GST-b1-AR third intracellular loop
incubation with bovine brain extracts.
Table 1. Description of clones identified by the yeast
two-hybrid system
Protein Clone Position
b-galactosidase activity,
mean 6 SE
SH3p4 2 aa 24-end 6.24 6 0.49
100 aa 104-end 3.09 6 0.31
SH3p13 6 aa 57-end 10.81 6 1.23
1 FL (132 aa) 4.26 6 0.21
3, 55 FL (136 aa) 3.94 6 0.2
9 FL (139 aa) 4.21 6 1.47
35 FL (137 aa) ND
The identity of the clone and the amino acids contained in each isolated
clone are shown. FL indicates that the entire open reading frame including
some of the 59 untranslated region is contained in the clone. The b-galacto-
sidase activity was determined by liquid assay using log phase cultures. The
numbers represent fold stimulation of activity as determined by co-transfor-
mation of the indicated plasmid with the b1-AR third intracellular loop into
the yeast strain PJ-69-4A in comparison with transformation of the indicated
plasmid with empty vector. Values of b-galactosidase activity are mean 6 SE
of three independent experiments. ND, not determined.
Fig. 2. (A) GST-SH3p4 binds to His-S-b1-AR third intracellular loop in a
saturable and SH3-dependent manner in vitro. An ELISA assay was carried out
as described in detail in Materials and Methods. In brief, His-S-b1 or b2-AR
third intracellular loop was coated on 96-well plates and was subsequently
overlaid with GST (control), GST-SH3p4 (F,), or SH3p4 DSH3 () for 1 hr at
room temperature. After washing with PBS, GST substrate was added to each
well, and the plates were read at 340 nm to record reaction kinetics (DODy
time). The binding activity of GST fusion proteins with His-S-b1 or b2-AR third
intracellular loop is presented as the fold increase in enzymatic activity over a
GST control. The results shown were obtained from three independent ex-
periments performed in duplicate (mean 6 SE). Note, for GST-SH3p4 DSH3
binding with His-b1-AR third intracellular loop and GST-SH3p4 binding with
His-b2-AR third intracellular loop, the error bars are smaller than the symbols.
(B) The b1-AR third intracellular loop specifically binds to SH3p4 but not to
other SH3-containing proteins. The ELISA assay was performed essentially as
described in A. The binding activity shown is the endpoint absorbance at 340
nm (subtracted by GST control absorbance) after incubation with GST sub-
strate for 1 hr at room temperature. For GST-SH3p4, GST-SH3p4DSH3, and
GST-SH3p4 SH3, the results shown were obtained from three independent
experiments (mean 6 SE). For all other GST fusion proteins, the results shown
are the average of two independent experiments.
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cellular loop revealed a saturable, high-affinity interaction be-
tween these two polypeptides (Kd 5 47 6 9 nM). In contrast,
there was no detectable interaction between His-S-tagged
b2-AR third intracellular loop fusion protein and GST-SH3p4.
SH3p4 contains a C-terminal SH3 domain that may represent
the site of interaction with the proline-rich b1-AR third intra-
cellular loop. Therefore, we also examined an SH3 domain-
deleted SH3p4 mutant (i.e., SH3p4 DSH3) in the ELISA assay.
As shown in Fig. 2 A, deletion of the SH3 domain completely
abolished the association of SH3p4 with the b1-AR third
intracellular loop. Moreover, the SH3 domain of SH3p4 alone
was also capable of binding to the b1-AR third intracellular loop,
although with lower affinity than full length SH3p4 (Fig. 2B).
The relatively weak binding of the SH3p4 SH3 domain alone to
the b1-AR third intracellular loop is consistent with previous
findings that isolated SH3 domains bind with lower affinity to
their cognate proline-rich peptide ligands than do full-length
proteins (20). These data suggest that regions other than SH3
domains are also important for the interactions between SH3
domains and proline-rich motif-containing proteins and dictate
the specificity of such interactions.
It has been well established that many cellular signaling events
are driven by interaction between proline-rich motifs and SH3
domains. Given the great diversity of the signaling events
occurring within cells, the specificity of such interactions must be
intricately controlled. Therefore, we decided to test the speci-
ficity of the interaction between the SH3 domain of SH3p4 and
the b1-AR third intracellular loop. We examined several SH3
domain-containing proteins for their ability to interact with the
b1-AR third intracellular loop, including the well studied
adapter protein Grb2, the tyrosine kinase Src, and the synaptic
vesicle trafficking protein amphiphysin 2 (also referred to as
amphiphysin-like-protein 1). As shown in Fig. 2B, neither GST-
Grb2 nor GST- ALP1 fusion proteins show detectable binding to
the b1-AR third intracellular loop. Similarly, GST fusion pro-
teins containing the SH3 domains from Src and Grb2 exhibit no
binding to the b1-AR third intracellular loop. Given the specific
nature of the association of the b1-AR third intracellular loop
with SH3p4, this interaction might have potential physiological
relevance.
SH3p4 Associates with the b1-Adrenergic Receptors in HEK293 Cells.
To verify that the in vitro interaction between SH3p4 and the
b1-AR third intracellular loop reflects the ability of these
proteins to interact in the cells, we overexpressed both proteins
in HEK293 cells and examined their association by co-
immunoprecipitation. HEK293 cells were transiently transfected
with pcDNA3 Flag-b1-AR and pcDNA3 HA-SH3p4. After
isoproterenol stimulation for various periods of time, cells were
lysed, and Flag-b1-ARs from cell lysates were immunoprecipi-
tated with anti-Flag affinity gel. The immunoprecipitates then
were analyzed by SDSyPAGE and Western blotting. The blots
were probed with anti-HA antibody to detect HA-SH3p4. Fig. 3
shows that SH3p4 interacts specifically with the b1-AR in intact
cells. However, no obvious effect of receptor occupancy on the
association of b1-ARs and SH3p4 was observed under our
experimental conditions. Consistent with the in vitro data, the
SH3 domain deletion mutant of SH3p4, although expressed in
cells at similar levels to the wild-type protein, does not co-
immunoprecipitate with the b1-AR. These data support the
conclusion that the interaction between the b1-AR and SH3p4
is mediated by the SH3 domain of SH3p4 and, presumably, the
proline-rich region of the b1 third intracellular loop. GST
pull-down assays and in vitro ELISA assays demonstrate that the
b2-AR third intracellular loop does not bind to SH3p4 (Figs. 1
and 2 A). Consistent with these observations, no immunoreactive
HA-SH3p4 was detected in the Flag-b2-AR immunoprecipitates
(Fig. 3 Right). These data further support the contention that the
SH3p4 protein may serve a specific role in b1-AR but not b2-AR
signaling.
Overexpression of SH3p4 Promotes Agonist-Induced Internalization
and Decreases the Gs-Coupling Efficacy of the b1-Adrenergic Recep-
tors in HEK293 Cells. On agonist stimulation, b1- and b2-
adrenergic receptors, like other GPCRs, internalize from the cell
surface to cytoplasmic vesicles via a classical clathrin-mediated
endocytosis pathway (9). Although the physiological significance
of this receptor internalization is not fully understood, internal-
ization of the b2-AR is critical for resensitization (21). Com-
pared with the b2-AR, the b1-AR undergoes sequestration to a
much lower extent. For example, it was previously reported that
agonist stimulation led to .30% b2-AR internalization in
Chinese hamster fibroblast cells whereas sequestration of the
b1-AR was negligible (6). More detailed characterization re-
vealed that the proline-rich region in the b1-AR third intracel-
lular loop appears to be responsible for its distinctive pattern of
sequestration (5). Therefore, we set out to determine whether
SH3p4 plays a specific role in b1-AR internalization. HEK293
cells were transiently transfected with either pcDNA1 HA-
b1-AR or pcDNA1 HA-b2-AR alone or together with pcDNA3
Flag-SH3p4. As shown in Fig. 4A, isoproterenol stimulation
induced ’15 and 30% sequestration for the b1-AR and the
b2-AR, respectively. Notably, overexpression of SH3p4 in-
creased agonist-induced b1-AR internalization to ’25% but had
no effect on the internalization of the b2-AR.
In addition to differences in their ability to undergo agonist-
induced receptor sequestration, the b1-AR and b2-AR also
exhibit differential coupling to Gs. It has been demonstrated that
the b1-AR couples to Gs less well than does the b2-AR (5, 13,
22). The EC50 of isoproterenol for activating adenylyl cyclase
through the b1-AR is ’5-fold higher than through the b2-AR
(13). Once again, the proline-rich region of the b1-AR third
intracellular loop has been suggested to contribute to this
Fig. 3. Coimmunoprecipitation of HA-SH3p4 and Flag-b1-adrenergic recep-
tor from HEK293 cells. pcDNA3 Flag-b1-AR (Left) or pcDNA3 Flag-b2-AR
(Right) were transiently transfected into HEK293 cells in the absence or
presence of pcDNA3 HA-SH3p4 or pcDNA3 HA-SH3p4 DSH3. Nonstimulated
cells and cells stimulated with 10 mM isoproterenol for various periods of time
were lysed in digitonin buffer. Flag-b1-AR was immunoprecipitated with M2
anti-Flag affinity gel from samples containing equal amounts of protein.
Immunoprecipitates were subjected to SDSyPAGE and Western blot analysis.
The blot was initially probed with anti-HA rabbit polyclonal antibody to detect
HA-SH3p4 and HA-SH3p4 DSH3. The blot was subsequently stripped and
reprobed with biotinylated-M2 anti-Flag antibody and streptavidiny
horseradish peroxidase conjugates to detect Flag-bAR. Overexpression of
HA-SH3p4 or HA-SH3p4DSH3 in whole cell lysate also was monitored. The
experiment was repeated at least three times with similar results. The diffuse
doublet of both Flag-b1-AR and Flag-b2-AR in the middle panel likely repre-
sents differentially glycosylated forms of these receptors.
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difference (13). To explore the possible role of SH3p4 in b1-AR
signaling, we examined whole-cell cAMP accumulation medi-
ated by the b1-AR in the presence or absence of SH3p4
overexpression. HEK293 cells stably expressing HA-SH3p4,
HA-SH3p4DSH3 or pcDNA3 were established, and pcDNA1
HA-b1-AR transiently transfected into these cells to test their
Gs coupling efficacy. The b1-AR-specific agonist dobutamine
was used to stimulate the cells. Dose-response curves are pre-
sented in Fig. 4B. Analysis of the curves reveals that overex-
pression of SH3p4 causes the EC50 to shift from 22 6 6 nM to
34 6 6 nM (P , 0.01). In contrast, overexpression of
SH3p4DSH3 did not affect the b1-AR-induced adenylyl cyclase
activity. Dobutamine did not stimulate adenylyl cyclase through
endogenous b2-ARs in HEK293 cells, indicating specificity of
dobutamine for the b1-ARs (data not shown). Moreover, when
isoproterenol was used to stimulate endogenous b2-AR in either
pcDNA3 empty vector or pcDNA3 SH3p4 stably transfected
cells, no difference in adenylyl cyclase activity was observed
(data not shown). These results provide further support for the
hypothesis that SH3p4 specifically affects b1-AR signaling.
Discussion
Here we report the identification of the members of SH3p4y
p8yp13 protein family as binding partners for the b1-AR. The
SH3p4yp8yp13 protein family, also referred to as endophilin
1y2y3, was first discovered as novel SH3-containing proteins by
screening a mouse embryonic cDNA expression library using a
proline-rich peptide ligand for the SH3 domain (20). With
respect to tissue distribution, SH3p4 is restricted to the brain and
SH3p8 is present in brain and testis whereas SH3p13 shows more
ubiquitous expression (23, 24). Recently, the SH3p4yp8yp13
protein family has been shown to form complexes with several
proteins, such as amphiphysin, synaptojanin, and dynamin, all of
which are implicated in presynaptic vesicle trafficking in nerve
terminals (24–26). Complex formation depends on the interac-
tion between proline-rich motifs and SH3 domains. It also has
been reported recently that human SH3p8 is associated with the
Huntingtin protein in an SH3-dependent manner and that this
association enhances the formation of polyglutamine-containing
protein aggregates (27). Here we report yet another aspect of the
potential physiological significance of this protein family by
demonstrating a specific interaction between SH3p4 and a
GPCR, the b1-AR. Furthermore, b1-ARySH3p4 complex for-
mation is shown to affect both b1-AR internalization and
signaling.
b1-AR and b2-AR are closely related b-adrenergic receptor
subtypes, sharing ’54% overall sequence homology (1). How-
ever, these two bAR subtypes are biologically distinguishable in
a number of respects. For instance, they show distinctive agonist
and antagonist binding affinities (13). Although both subtypes
couple to Gs and activate adenylyl cyclase on agonist stimulation,
the Gs coupling efficacy of the b1-AR is lower than that of the
b2-AR (5, 22). b2-ARs are also able to couple to Gi. Moreover,
b1 and b2-AR display distinctive tissue distribution patterns and
serve different physiological roles. The b1-AR is the predomi-
nant b adrenergic receptor in heart whereas the b2-AR pre-
dominates in liver, lung, and smooth muscle (2). Both transgenic
(28–30) and gene ‘‘knock-out’’ mouse models (31, 32) have been
established for the b1- and b2-ARs, resulting in different
physiological and developmental outcomes.
It has been noted that the b1-AR third intracellular loop
contains a unique 24-aa proline-rich segment, which has no
counterpart in the b2-AR (13). Previous studies have suggested
that this sequence disparity between the b1- and b2-ARs might
function as one of the molecular determinants for their distin-
guishable signaling features (13). Our in vitro assay shows that
SH3p4 interacts with the b1-AR third intracellular loop in a
saturable and SH3-dependent manner. In intact cells, SH3p4
coimmunoprecipitates with the b1-AR, and the SH3 domain of
SH3p4 is required for this association. Receptor occupancy does
not appear to affect b1ARySH3p4 complex formation. Agonist
stimulation may, however, alter SH3p4 conformation or lead to
the convalent modification of this protein, processes that may
modulate downstream signaling events. There are precedents for
such a possibility. For example, in the case of the AMPA
receptor (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate),
a ligand-gated cation channel, the extent of physical association
of the AMPA receptors with Lyn, an SH3-containing tyrosine
kinase, is not altered after AMPA stimulation. Instead, agonist
binding causes a significant increase in the tyrosine kinase
activity of Lyn and subsequently leads to mitogen-activated
protein kinase activation (33).
Interactions driven by SH3 domains and proline-rich motifs
are among the most common events found in many cellular
processes, such as cytoskeleton organization, subcellular local-
ization of signaling molecules, and vesicle endocytosis (34).
However, the role of SH3 domain-mediated interactions in
b-adrenergic receptor and other GPCR signaling has not been
extensively studied. Proline-rich regions have been found in
intracellular domains of a number of GPCRs, including b1-AR,
b3-AR, a2A-AR, and dopamine D4 receptor, and a few studies
have been attempted to understand their potential roles in
Fig. 4. (A) Internalization of HA-b1-AR in HEK293 cells is potentiated on
overexpression of SH3p4. HEK293 cells were transiently transfected with 0.5–1
mg of pCDNA1 HA-b1-AR or HA-b2-AR to obtain a receptor expression level of
500 fmolymg protein in the presence or absence of pcDNA3 Flag-SH3p4. Cells
were stimulated with 10 mM isoproterenol for 30 min. Results are presented
as the percentage loss of cell surface receptor. For HA-b1-AR, n 5 9, P ,
0.01(pp) for comparison of HA-b1-AR internalization in the presence versus
absence of SH3p4 according to Student’s t test; for HA-b2-AR, n 5 5. (B)
Overexpression of SH3p4 in HEK293 cells attenuates HA-b1-AR stimulated
adenylyl cyclase activity. Stable HEK293 cells, overexpressing pcDNA3 HA-
SH3p4, pcDNA3 HA-SH3p4 DSH3, or pcDNA3 empty vector, were transfected
with pCDNA1 HA-b1-AR to achieve a receptor concentration of ’500 fmolymg
protein. HA-b1-AR was stimulated for 10 min with the indicated concentra-
tions of dobutamine. Whole cell cAMP accumulation was measured as the
percentage conversion of [3H]adenine to [3H]cAMP. cAMP accumulation on 50
mM forskolin stimulation was used to normalize dobutamine-induced cAMP
production. The cyclase activity observed in the presence of HA-b1-AR over-
expression in the pcDNA3-stable HEK293 cells at 10 mM dobutamine is set at
100. The other data points are shown as percentage of this maximal cyclase
activity. The means 6 SE from four independent experiments are shown.
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GPCR signaling. In vitro, the SH2-SH3 adapter proteins, Grb2
and Nck, have been shown to interact with the proline-rich third
intracellular loop of dopamine D4 receptor (14). Furthermore,
removal of the putative SH3 binding sites from the third intracel-
lular loop resulted in constitutive internalization of the mutant
D4 receptors and deficient activation of second messengers (14).
Our studies demonstrate that overexpression of SH3p4 in-
creases agonist-induced sequestration and modestly decreases
the Gs coupling efficacy of the b1-AR in HEK293 cells. What is
the role of SH3p4 in b1-AR internalization and signaling? It has
been well established, largely by using the b2-AR as a model
system, that GRK-catalyzed phosphorylation followed by b-ar-
restin binding leads to endocytosis of the b2-AR(3). b-arrestin
is thought to target the receptors to the clathrin-coated vesicles.
It also has been shown that the b1-AR can be phosphorylated by
GRKs (19). However, it was previously proposed that the b1-AR
might be a poorer substrate for GRKs and b-arrestins than the
b2-AR (35). It is possible that endocytosis of the b1-AR may use
different protein components than the b2-AR. It has been
reported recently that SH3-containing proteins, including
SH3p4, function sequentially in endocytic clathrin-coated vesicle
formation (36). Thus, SH3p4 may act as an adapter protein by
directing the b1-AR to the endocytic machinery. In support of
this hypothesis is the evidence that SH3p4 can form homodimers
in vivo (N.R. and P.D., unpublished data). The dimerization of
SH3p4 may facilitate simultaneous binding of SH3p4 with the
b1-AR and its downstream binding partner(s). Although the
downstream binding partner(s) for SH3p4 in b1-AR endocytosis
remains to be identified, in vitro studies have indicated that
SH3p4 is capable of interacting with the carboxy-terminal pro-
lineyarginine-rich domain (PRD) of the GTPase dynamin, which
is recruited to the necks of the clathrin-coated pits and regulates
the fission reaction (24, 26).
In addition to its effect on b1AR internalization, SH3p4
binding to the third intracellular loop alters the coupling of the
b1-AR to the Gs protein. It was shown previously that the N- and
C- terminal ends of the b-adrenergic receptor third intracellular
loops dictate their G protein coupling efficacy and specificity (7,
8). It is conceivable that binding of SH3p4 to the middle segment
of the b1-AR third intracellular loop alters stimulation of the Gs
protein, either by physically interfering with receptor Gs protein
coupling or by altering receptor conformation, thus lowering
agonist binding affinity. In either case, rightward and downward
shift of the dose-response curve on overexpression of SH3p4 is
observed.
Previous studies have implicated the 24-aa proline-rich region
of the b1-AR third intracellular loop as contributing to differ-
ences in the internalization and signaling properties of b1-ARs
vs. b2-ARs in Chinese hamster fibroblast cells (13). Our studies
further support the hypothesis that this proline-rich region may
serve as a molecular determinant for b1-AR functionality by
interacting with SH3 domain-containing protein(s). The molec-
ular consequences of the b1-ARySH3p4 interaction remain to be
further elucidated. However, the findings reported here under-
score the likelihood that interactions between proline-rich mo-
tifs in GPCRs and SH3-containing proteins are likely to play
important roles in previously unappreciated aspects of GPCR
signaling.
Note Added in Proof. Endophilin 1 (i.e., SH3p4) has recently been
demonstrated to exhibit lysophosphatidic acid acyl transferase activity
(37) and mediate synaptic vesicle invagination (38).
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